Literature DB >> 27287398

Measurements of Intracellular Ca2+ Content and Phosphatidylserine Exposure in Human Red Blood Cells: Methodological Issues.

Mauro C Wesseling, Lisa Wagner-Britz, Fatima Boukhdoud, Salome Asanidze, Duc Bach Nguyen, Lars Kaestner, Ingolf Bernhardt.   

Abstract

BACKGROUND/AIMS: The increase of the intracellular Ca2+ content as well as the exposure of phosphatidylserine (PS) on the outer cell membrane surface after activation of red blood cells (RBCs) by lysophosphatidic acid (LPA) has been investigated by a variety of research groups. Carrying out experiments, which we described in several previous publications, we observed some discrepancies when comparing data obtained by different investigators within our research group and also between batches of LPA. In addition, we found differences comparing the results of double and single labelling experiments (for Ca2+ and PS). Furthermore, the results of PS exposure depended on the fluorescent dye used (annexin V-FITC versus annexin V alexa fluor® 647). Therefore, it seems necessary to investigate these methodological approaches in more detail to be able to quantify results and to compare data obtained by different research groups.
METHODS: The intracellular Ca2+ content and the PS exposure of RBCs separated from whole blood have been investigated after treatment with LPA (2.5 µM) obtained from three different companies (Sigma-Aldrich, Cayman Chemical Company, and Santa Cruz Biotechnology Inc.). Fluo-4 and x-rhod-1 have been used to detect intracellular Ca2+ content, annexin V alexa fluor® 647 and annexin V-FITC have been used for PS exposure measurements. Both parameters (Ca2+ content, PS exposure) were studied using flow cytometry and fluorescence microscopy.
RESULTS: The percentage of RBCs showing increased intracellular Ca2+ content as well as PS exposure changes significantly between different LPA manufacturers as well as on the condition of mixing of LPA with the RBC suspension. Furthermore, the percentage of RBCs showing PS exposure is reduced in double labelling compared to single labelling experiments and depends also on the fluorescent dye used. Finally, data on Ca2+ content are slightly affected whereas PS exposure data are not affected significantly by the measuring method (flow cytometry, fluorescence microscopy).
CONCLUSION: The LPA batch used and the mixing procedure of LPA and the RBC suspension has to be taken into consideration when comparing results of intracellular Ca2+ content and PS exposure of RBCs after LPA activation. In addition, one should consider that the results of single and double labelling experiments might be different depending on the fluorescent dyes used.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27287398     DOI: 10.1159/000445593

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Red Cell Properties after Different Modes of Blood Transportation.

Authors:  Asya Makhro; Rick Huisjes; Liesbeth P Verhagen; María Del Mar Mañú-Pereira; Esther Llaudet-Planas; Polina Petkova-Kirova; Jue Wang; Hermann Eichler; Anna Bogdanova; Richard van Wijk; Joan-Lluís Vives-Corrons; Lars Kaestner
Journal:  Front Physiol       Date:  2016-07-15       Impact factor: 4.566

Review 2.  The Proteome of the Red Blood Cell: An Auspicious Source of New Insights into Membrane-Centered Regulation of Homeostasis.

Authors:  Giel J C G M Bosman
Journal:  Proteomes       Date:  2016-11-25

Review 3.  Heterogeneity of Red Blood Cells: Causes and Consequences.

Authors:  Anna Bogdanova; Lars Kaestner; Greta Simionato; Amittha Wickrema; Asya Makhro
Journal:  Front Physiol       Date:  2020-05-07       Impact factor: 4.566

4.  18F-fluorodeoxyglucose positron emission tomography-computed tomography for assessing organ distribution of stressed red blood cells in mice.

Authors:  Wen-Yu Yin; Jiao Yuan; Zhi-Min Zhang; Cheng Mei; Wei Xu; Yong-Xiang Tang; Fang Peng; Ning Li
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.